These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4062438)

  • 1. A cardiac antiarrhythmic screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Zhan CY; Mok CP; Wong TM
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):217-22. PubMed ID: 4062438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic potency of naloxone determined by a screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Wong TM
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):212-5. PubMed ID: 3592865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
    Baker T; Erker EF
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiarrhythmic drugs on the postischaemic metabolic recovery of isolated rat hearts.
    Latocha G; Bernauer W
    Arch Int Pharmacodyn Ther; 1991; 312():39-54. PubMed ID: 1772339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental effects of anti-arrhythmic drugs on ventricular fibrillation thresholds altered by regional hyperkalemia.
    Logic JR
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):268-74. PubMed ID: 4748780
    [No Abstract]   [Full Text] [Related]  

  • 7. Rational use of antiarrhythmic drugs alone and in combination.
    Bigger JT; Giardina EG
    Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
    Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
    Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Johnson GL; Ehrreich SJ; el-Hage AN; Balazs T
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):351-64. PubMed ID: 3704313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
    Manning AS; Crome R; Isted K; Coltart DJ; Hearse DJ
    Adv Myocardiol; 1985; 6():515-28. PubMed ID: 2581300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utilization of anti-arrhythmic drugs].
    Perrenoud JJ
    Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method for the production of severe ventricular dysrhythmias in small laboratory animals.
    Guideri G; Barletta M; Chau R; Green M; Lehr D
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():661-79. PubMed ID: 1209009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane postconditioning converts persistent ventricular fibrillation into regular rhythm.
    Zhang F; Chen G; Chen C; Yan M
    Eur J Anaesthesiol; 2009 Sep; 26(9):766-71. PubMed ID: 19367168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of antiarrhythmic drugs.
    Lucchesi BR; Lynch JJ
    Fed Proc; 1986 Jul; 45(8):2197-205. PubMed ID: 3720962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of fructose-1,6-diphosphate and phosphoenolpyruvate on the course of early occlusion and reperfusion arrhythmias in rats].
    Balashov VP; Kostin IaV; Sedova DG; Sernov LN; Gatsura VV
    Biull Eksp Biol Med; 1993 Jun; 115(6):629-30. PubMed ID: 8374147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine revisited.
    Yang F; Hanon S; Lam P; Schweitzer P
    Am J Med; 2009 Apr; 122(4):317-21. PubMed ID: 19249010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrilation threshold curves and anti-arrhythmic drugs.
    Vanremoortere E; Wauters E
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):476-9. PubMed ID: 5715418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of the mechanisms of the anti-arrhythmic action of marcaine and lidocaine].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu; Dzhaparidze MM
    Farmakol Toksikol; 1984; 47(3):46-50. PubMed ID: 6734807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.